Journal of Clinical Lipidology

Papers
(The H4-Index of Journal of Clinical Lipidology is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Comparison of virtual vs face-to-face medical nutrition therapy in patients with hyperlipidemia244
Hypercoagulability or coronary artery disease? Polygenic risk score unveils the mystery154
Effective treatment of statin- and ezetimibe-resistant hyperlipidemia in a patient with active membranous nephrotic syndrome using a PCSK9 inhibitor111
Assessment of health disparities in secondary ASCVD risk prevention in the elderly population in Greece95
Lipoprotein(a) concentrations across a global cross-sectional registry93
Disparities in statin use among individuals with and without cancer history across atherosclerotic cardiovascular disease risk categories86
Genetic mutations and associated phenotypes in familial hypercholesterolemia: A biobank study81
Care of youth with lipid disorders: A brief provider survey74
†Role of DNA methylation on 15-Lipoxygenase-1 gene expression in Osteoarthritis71
Mesenchymal Stromal Cell (MSC) Therapy Improve Nonalcoholic Fatty Liver Disease (NAFLD) in Long Term high Fat Diet (HFD) Induced Obesity (DIO) Mouse66
Lower Activity of Cholesteryl Ester Transfer protein (CETP) and the Risk of Dementia: A Mendelian Randomization Analysis66
The Effect of Estrogen and Testosterone on Cholesterol Crystallization56
News from NLA51
Genetic Testing for Hypertriglyceridemia in Academic Lipid Clinics - Implications for Precision Medicine51
From the Editors: New insights into lipid disorders in children and adolescents as well as cardiovascular benefits of pharmacotherapy for weight loss45
Prevalence of Lipoprotein(a) Measurements in Patients with or at Risk of Cardiovascular Disease43
Relation of red blood cell distribution width to risk of major adverse cardiovascular events, death, and effect of alirocumab after acute coronary syndromes43
Socioeconomic Disparities in Dyslipidemia and Associated Complications: From the Latest National Database43
The impact of genetic testing on physician practice in specialized cardiovascular clinics42
Niacin (Niacin) and clinical utility, don't be misled by recent niacin (Niacin) metabolite report42
Managing hypercholesterolemia in adults older than 75 years without a history of atherosclerotic cardiovascular disease: An Expert Clinical Consensus from the National Lipid Association and the Americ40
Lipoprotein(a) levels in children with homozygous familial hypercholesterolaemia: A cross-sectional study38
Exciting new developments in clinical lipidology: Updates from the Food and Drug Administration and the American Heart Association37
Healthcare utilization and expenditures among adults with severe hypertriglyceridemia in US clinical practice36
Association of Lipoprotein(a) with peri-coronary inflammation in persons with and without HIV infection34
Impact of providing genetics-based future cardiovascular risk on LDL-C in patients with familial hypercholesterolemia34
Inflammation and cardiometabolic disease in South Asians: The fire and fire tenders34
Achievement of low-density lipoprotein cholesterol thresholds in very high-risk atherosclerotic cardiovascular disease33
Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association31
Predictive value of lipoprotein(a) in patients undergoing percutaneous coronary intervention with drug-eluting stent: A meta-analysis31
Lipoprotein lipase DNA methylation in the adipose tissue of patients with persistent chylomicronemia31
0.21451306343079